ComputerTalk for the Pharmacist September/October 2022
PHSL Senior Consultants Patty Milazzo and Dave Schuetz contributed to the September/October 2022 edition of ComputerTalk for the Pharmacist. In their first Viewpoints article of a series, Patty and Dave discuss the FDA’s proposed solution to changing the NDC structure, an explanation of the stepped, multiyear approach, and key projected dates for the multiphase implementation.
Click here to read the article “Understanding the FDA’s Plans for NDCs.” You can also access the full versions of current and past ComputerTalk issues at https://www.computertalk.com/issue-archive/.
Poll Results
February 2023 Question of the Month
Do you feel like your organization understands the FDA’s Draft Guidance for Industry on Drug Importation?
We have reviewed the guidance and are taking a watch and wait approach: 75%
We have reviewed the guidance and are taking proactive steps to act on it: 25%
We have reviewed the guidance but do not feel like it will impact our organization: 0%
Not familiar/We have not reviewed the guidance: 0%
January 2023 Question of the Month
How will payers manage reimbursement of multiple interchangeable biosimilars?
MAC reimbursement: 10%
Generic non-MAC reimbursement rate: 10%
Brand reimbursement rate: 40%
Specialty drug specific rate: 40%
Average Sales Price (ASP): 0%
Average Manufacturer Price (AMP): 0%
National Average Drug Acquisition Cost (NADAC): 0%
December 2022 Question of the Month
In which area could you or your company most benefit from additional training?
Biosimilars and interchangeability requirements: 46.1%
Dynamics that drive PBM and health plan decisions: 15.4%
Various hurdles a prescription must clear before being dispensed: 15.4%
Changing 340B landscape: 15.4%
Flow of funds and prescriptions through the pharmacy channels: 7.7%
Pharmacy chain initiatives and strategy updates: 0%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
